Savara Inc.

SVRA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$5.33-2.38%

2026-08-03

Financials

Valuation Metrics

Savara Inc.'s Market Cap is $1.09B. At end of 2025 it was $1.34B. Ranked #2456 of 3,112 in US market (top 79%), #999 of 1,445 on NASDAQ (top 69%), #188 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 70%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.09B	US#2,456/3,112 Sec#188/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-129M	US—/3,112 Sec—/269
Total Assets	$222M	US#2,962/3,112 Sec#243/269
Net Assets	$176M	US#2,773/3,112 Sec#205/269
Value
P/B	6.20x	US#2,334/3,112 Sec#162/269
FCF Yield	-9.79%	US—/3,112 Sec—/269
Profitability
ROE	-73.55%	US#2,814/3,112 Sec#206/269
ROA	-58.42%	US#2,993/3,112 Sec#233/269
Financial Health
Debt Ratio	25.91%	US#281/3,112 Sec#90/269
Total Debt	$30M	US#2,642/3,112 Sec#168/269
FCF	$-107M	US#2,600/3,112 Sec#155/269
Cash	$39M	US#2,681/3,112 Sec#240/269
Current Ratio	13.47x	US#182/3,112 Sec#61/269
Performance
1Y Return	105.79%	US#273/3,112 Sec#76/269
1M Return	-14.31%	US#2,786/3,112 Sec#198/269
From 52W High	-23.97%	US#1,901/3,112 Sec#132/269
1Y MDD	-31.99%	US#1,512/3,112 Sec#95/269
Trading
Volume	1,602,032 shares	US#1,069/3,112 Sec#95/269
Trading Value	$9M	US#2,411/3,112 Sec#190/269
Per Share
EPS	$-0.53	US—/3,112 Sec—/269
BPS	$0.91	US#2,633/3,112 Sec#205/269